139 related articles for article (PubMed ID: 17724471)
41. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
Liu R; Yin LH; Pu YP
Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
[TBL] [Abstract][Full Text] [Related]
42. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
[TBL] [Abstract][Full Text] [Related]
43. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain.
Esteban Cardeñosa E; Bolufer Gilabert P; Palanca Suela S; Oltra Soler S; Barragán González E; Velasco Sampedro E; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E;
Breast Cancer Res Treat; 2008 Nov; 112(1):69-73. PubMed ID: 18060494
[TBL] [Abstract][Full Text] [Related]
44. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.
Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM
Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569
[TBL] [Abstract][Full Text] [Related]
45. Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran.
Akbari MR; Malekzadeh R; Shakeri R; Nasrollahzadeh D; Foumani M; Sun Y; Pourshams A; Sadjadi A; Jafari E; Sotoudeh M; Kamangar F; Boffetta P; Dawsey SM; Ghadirian P; Narod SA
Cancer Res; 2009 Oct; 69(20):7994-8000. PubMed ID: 19826048
[TBL] [Abstract][Full Text] [Related]
46. Candidate susceptibility variants for esophageal squamous cell carcinoma.
Donner I; Katainen R; Tanskanen T; Kaasinen E; Aavikko M; Ovaska K; Artama M; Pukkala E; Aaltonen LA
Genes Chromosomes Cancer; 2017 Jun; 56(6):453-459. PubMed ID: 28165652
[TBL] [Abstract][Full Text] [Related]
47. Chinese hamster cell mutant, V-C8, a model for analysis of Brca2 function.
Wiegant WW; Overmeer RM; Godthelp BC; van Buul PP; Zdzienicka MZ
Mutat Res; 2006 Aug; 600(1-2):79-88. PubMed ID: 16643964
[TBL] [Abstract][Full Text] [Related]
48. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.
Obazee O; Archibugi L; Andriulli A; Soucek P; Małecka-Panas E; Ivanauskas A; Johnson T; Gazouli M; Pausch T; Lawlor RT; Cavestro GM; Milanetto AC; Di Leo M; Pasquali C; Hegyi P; Szentesi A; Radu CE; Gheorghe C; Theodoropoulos GE; Bergmann F; Brenner H; Vodickova L; Katzke V; Campa D; Strobel O; Kaiser J; Pezzilli R; Federici F; Mohelnikova-Duchonova B; Boggi U; Lemstrova R; Johansen JS; Bojesen SE; Chen I; Jensen BV; Capurso G; Pazienza V; Dervenis C; Sperti C; Mambrini A; Hackert T; Kaaks R; Basso D; Talar-Wojnarowska R; Maiello E; Izbicki JR; Cuk K; Saum KU; Cantore M; Kupcinskas J; Palmieri O; Delle Fave G; Landi S; Salvia R; Fogar P; Vashist YK; Scarpa A; Vodicka P; Tjaden C; Iskierka-Jazdzewska E; Canzian F
Int J Cancer; 2019 Aug; 145(3):686-693. PubMed ID: 30672594
[TBL] [Abstract][Full Text] [Related]
49. p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area.
Mir MM; Dar NA; Gochhait S; Zargar SA; Ahangar AG; Bamezai RN
Int J Cancer; 2005 Aug; 116(1):62-8. PubMed ID: 15761872
[TBL] [Abstract][Full Text] [Related]
50. Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness.
Tischkowitz M; Gologan A; Srolovitz H; Khanna M; Foulkes WD
Br J Cancer; 2006 Jul; 95(2):243-4. PubMed ID: 16786041
[No Abstract] [Full Text] [Related]
51. The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility.
Tuominen R; Engström PG; Helgadottir H; Eriksson H; Unneberg P; Kjellqvist S; Yang M; Lindén D; Edsgärd D; Hansson J; Höiom V
Genes Chromosomes Cancer; 2016 Jul; 55(7):601-11. PubMed ID: 27074266
[TBL] [Abstract][Full Text] [Related]
52. Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma.
Cannella S; Santoro A; Bruno G; Pillon M; Mussolin L; Mangili G; Rosolen A; Aricò M
Cancer; 2007 Jun; 109(12):2566-71. PubMed ID: 17477373
[TBL] [Abstract][Full Text] [Related]
53. Esophageal cancer: cases and causes (part I).
Lambert R; Hainaut P
Endoscopy; 2007 Jun; 39(6):550-5. PubMed ID: 17554654
[No Abstract] [Full Text] [Related]
54. A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer.
Delahaye-Sourdeix M; Anantharaman D; Timofeeva MN; Gaborieau V; Chabrier A; Vallée MP; Lagiou P; Holcátová I; Richiardi L; Kjaerheim K; Agudo A; Castellsagué X; Macfarlane TV; Barzan L; Canova C; Thakker NS; Conway DI; Znaor A; Healy CM; Ahrens W; Zaridze D; Szeszenia-Dabrowska N; Lissowska J; Fabianova E; Mates IN; Bencko V; Foretova L; Janout V; Curado MP; Koifman S; Menezes A; Wünsch-Filho V; Eluf-Neto J; Boffetta P; Fernández Garrote L; Polesel J; Lener M; Jaworowska E; Lubiński J; Boccia S; Rajkumar T; Samant TA; Mahimkar MB; Matsuo K; Franceschi S; Byrnes G; Brennan P; McKay JD
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25838448
[TBL] [Abstract][Full Text] [Related]
55. Should a BRCA2 stop codon human variant, usually considered a polymorphism, be classified as a predisposing mutation?
D'Argenio V; Esposito MV; Gilder JA; Frisso G; Salvatore F
Cancer; 2014 May; 120(10):1594-5. PubMed ID: 24500773
[No Abstract] [Full Text] [Related]
56. Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, Iran.
Abedi-Ardekani B; Kamangar F; Sotoudeh M; Villar S; Islami F; Aghcheli K; Nasrollahzadeh D; Taghavi N; Dawsey SM; Abnet CC; Hewitt SM; Fahimi S; Saidi F; Brennan P; Boffetta P; Malekzadeh R; Hainaut P
PLoS One; 2011; 6(12):e29488. PubMed ID: 22216294
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of conformational transitions of h-BRCA2 functional domain and unclassified variant Arg2502Cys using multimodal approach.
Khan MA; Siddiqui MQ; Kuligina E; Varma AK
Int J Biol Macromol; 2022 Jun; 209(Pt A):716-724. PubMed ID: 35413318
[TBL] [Abstract][Full Text] [Related]
58. Genetic Profile and Microsatellite Instability in a Case of Secondary Esophageal Squamous Cell Carcinoma 12 Years After Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.
Akiyama M; Yamaoka M; Ohyama W; Yokoi K; Ashizuka S; Aizawa D; Ikegami M; Suzuki H; Ozaki K; Ida H; Yuza Y
J Pediatr Hematol Oncol; 2020 May; 42(4):302-306. PubMed ID: 30499911
[TBL] [Abstract][Full Text] [Related]
59. Exceptional Response to Olaparib: A Case Report of Metastatic Esophageal Squamous Cell Carcinoma in a Patient With Fanconi Anemia, Germline
Haggstrom LR; Tucker K; Williams R; Nelson A; Walsh R; Brungs D; Aghmesheh M
JCO Precis Oncol; 2023 Sep; 7():e2300221. PubMed ID: 37725782
[No Abstract] [Full Text] [Related]
60. Medicine. Possible new role for BRCA2.
Marx J
Science; 2004 Sep; 305(5691):1691. PubMed ID: 15375235
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
